BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 34083028)

  • 1. FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
    Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
    Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor.
    Färkkilä A; McConechy MK; Yang W; Talhouk A; Ng Y; Lum A; Morin RD; Bushell K; Riska A; McAlpine JN; Gilks CB; Unkila-Kallio L; Anttonen M; Huntsman DG
    J Mol Diagn; 2017 Jan; 19(1):126-136. PubMed ID: 27810330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
    Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
    J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary.
    Da Cruz Paula A; da Silva EM; Segura SE; Pareja F; Bi R; Selenica P; Kim SH; Ferrando L; Vahdatinia M; Soslow RA; Vidal A; Gatius S; Przybycin CG; Abu-Rustum NR; Matias-Guiu X; Rubin BP; Reis-Filho JS; DeLair DF; Weigelt B
    Mod Pathol; 2020 Aug; 33(8):1606-1617. PubMed ID: 32203090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted
    Alexiadis M; Rowley SM; Chu S; Leung DTH; Stewart CJR; Amarasinghe KC; Campbell IG; Fuller PJ
    Mol Cancer Res; 2019 Jan; 17(1):177-185. PubMed ID: 30166312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
    Färkkilä A; Haltia UM; Tapper J; McConechy MK; Huntsman DG; Heikinheimo M
    Ann Med; 2017 Aug; 49(5):435-447. PubMed ID: 28276867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Composite Serous Borderline Tumor and Adult Granulosa Cell Tumor-like Area: Is it a True Neoplastic AGCT or Tumor-like Proliferation?
    Yu J; Nie X
    Int J Gynecol Pathol; 2017 May; 36(3):265-269. PubMed ID: 27648785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.
    Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG
    PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype.
    McConechy MK; Färkkilä A; Horlings HM; Talhouk A; Unkila-Kallio L; van Meurs HS; Yang W; Rozenberg N; Andersson N; Zaby K; Bryk S; Bützow R; Halfwerk JB; Hooijer GK; van de Vijver MJ; Buist MR; Kenter GG; Brucker SY; Krämer B; Staebler A; Bleeker MC; Heikinheimo M; Kommoss S; Blake Gilks C; Anttonen M; Huntsman DG
    J Natl Cancer Inst; 2016 Nov; 108(11):. PubMed ID: 27297428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
    Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.
    Fashedemi Y; Coutts M; Wise O; Bonhomme B; Baker G; Kelly PJ; Soubeyran I; Catherwood MA; Croce S; McCluggage WG
    Am J Surg Pathol; 2019 Sep; 43(9):1229-1238. PubMed ID: 31162286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous Borderline Tumor of the Ovary.
    Guerrieri C; Hudacko R; Anderson P
    Int J Gynecol Pathol; 2023 Sep; 42(5):500-507. PubMed ID: 36044294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TERT promoter mutation in adult granulosa cell tumor of the ovary.
    Pilsworth JA; Cochrane DR; Xia Z; Aubert G; Färkkilä AEM; Horlings HM; Yanagida S; Yang W; Lim JLP; Wang YK; Bashashati A; Keul J; Wong A; Norris K; Brucker SY; Taran FA; Krämer B; Staebler A; van Meurs H; Oliva E; Shah SP; Kommoss S; Kommoss F; Gilks CB; Baird DM; Huntsman DG
    Mod Pathol; 2018 Jul; 31(7):1107-1115. PubMed ID: 29449679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Circulating Tumor DNA in Patients with Ovarian Cancer Harboring Somatic PIK3CA or KRAS Mutations.
    Ogasawara A; Hihara T; Shintani D; Yabuno A; Ikeda Y; Tai K; Fujiwara K; Watanabe K; Hasegawa K
    Cancer Res Treat; 2020 Oct; 52(4):1219-1228. PubMed ID: 32599986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
    Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
    Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO1 mitigates the SMAD3/FOXL2
    Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
    J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
    Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
    Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXL2 Mutation Status in Granulosa Theca Cell Tumors of the Ovary.
    Nolan A; Joseph NM; Sangoi AR; Rabban J; Zaloudek C; Garg K
    Int J Gynecol Pathol; 2017 Nov; 36(6):568-574. PubMed ID: 28319575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.